Kuros Biosciences Ag Stock Price Patterns

CSBTF Stock  USD 31.91  0.00  0.00%   
As of 10th of February 2026 the relative strength index (rsi) of Kuros Biosciences' share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 6

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Kuros Biosciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Kuros Biosciences and does not consider all of the tangible or intangible factors available from Kuros Biosciences' fundamental data. We analyze noise-free headlines and recent hype associated with Kuros Biosciences AG, which may create opportunities for some arbitrage if properly timed.
Using Kuros Biosciences hype-based prediction, you can estimate the value of Kuros Biosciences AG from the perspective of Kuros Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Kuros Biosciences to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Kuros because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Kuros Biosciences after-hype prediction price

    
  USD 31.91  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Kuros Biosciences Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kuros Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
28.7233.6635.39
Details

Kuros Biosciences After-Hype Price Density Analysis

As far as predicting the price of Kuros Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kuros Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Kuros Biosciences, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Kuros Biosciences Estimiated After-Hype Price Volatility

In the context of predicting Kuros Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kuros Biosciences' historical news coverage. Kuros Biosciences' after-hype downside and upside margins for the prediction period are 30.18 and 33.64, respectively. We have considered Kuros Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
31.91
31.91
After-hype Price
33.64
Upside
Kuros Biosciences is very steady at this time. Analysis and calculation of next after-hype price of Kuros Biosciences is based on 3 months time horizon.

Kuros Biosciences Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Kuros Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kuros Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kuros Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.19 
1.73
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
31.91
31.91
0.00 
0.00  
Notes

Kuros Biosciences Hype Timeline

Kuros Biosciences is currently traded for 31.91. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kuros is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.19%. %. The volatility of related hype on Kuros Biosciences is about 0.0%, with the expected price after the next announcement by competition of 31.91. About 35.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.79. Some equities with similar Price to Book (P/B) outperform the market in the long run. Kuros Biosciences recorded a loss per share of 0.24. The entity had not issued any dividends in recent years. The firm had 1:100 split on the 23rd of June 2016. Assuming the 90 days horizon the next anticipated press release will be in 5 to 10 days.
Check out Kuros Biosciences Basic Forecasting Models to cross-verify your projections.

Kuros Biosciences Related Hype Analysis

Having access to credible news sources related to Kuros Biosciences' direct competition is more important than ever and may enhance your ability to predict Kuros Biosciences' future price movements. Getting to know how Kuros Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kuros Biosciences may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CSPHFCStone Pharmaceuticals 0.00 0 per month 0.00 (0.09) 0.00  0.00  27.97 
SNBIFSanBio Company Limited 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
PHMMFPharma Mar SAU 0.00 0 per month 0.00 (0.14) 0.00 (0.12) 7.16 
PPTDFPeptiDream 0.00 0 per month 0.00 (0.04) 5.00 (6.15) 20.35 
ASCLFAscletis Pharma 0.00 0 per month 3.63  0.14  13.14 (4.69) 52.45 
PHGUFPharming Group NV 0.00 0 per month 0.00  0.11  7.84  0.00  27.50 
NURPFNeuren Pharmaceuticals Limited 0.00 0 per month 0.00 (0.10) 0.16 (5.11) 20.18 
CHIZFChina Traditional Chinese 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NPPNYNippon Shinyaku Co 0.00 0 per month 6.30  0.1  8.72 (3.44) 189.41 
MEOBFMesoblast 0.00 0 per month 0.00  0.05  0.00  0.00  57.06 

Kuros Biosciences Additional Predictive Modules

Most predictive techniques to examine Kuros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kuros using various technical indicators. When you analyze Kuros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Kuros Biosciences Predictive Indicators

The successful prediction of Kuros Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kuros Biosciences AG, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kuros Biosciences based on analysis of Kuros Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kuros Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kuros Biosciences's related companies.

Currently Active Assets on Macroaxis

Complementary Tools for Kuros Pink Sheet analysis

When running Kuros Biosciences' price analysis, check to measure Kuros Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kuros Biosciences is operating at the current time. Most of Kuros Biosciences' value examination focuses on studying past and present price action to predict the probability of Kuros Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kuros Biosciences' price. Additionally, you may evaluate how the addition of Kuros Biosciences to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing